Creative Disruption? She's 29 and Set to Reboot Lab Medicine

Elizabeth Holmes plans to revolutionize testing by using tiny blood draws and offering near-instantaneous results

; Elizabeth Holmes

| Disclosures | November 18, 2013

Fast-Forward: The Next Act

Dr. Topol: Let's go into fast-forward a little bit. You haven't even hit 30 yet. You've got Theranos, it's completely humming and doing everything that you've described. What is going to be your next act? You are so young to have accomplished so much.

Ms. Holmes: This is it. This is what I want to do.

Dr. Topol: Is that right? No SpaceX or hyperloop or anything like that in your plans?

Ms. Holmes: To really do this and make this change, this is what I want to do for the rest of my life.

Dr. Topol: Wow, amazing. We have really enjoyed the chance to get to know you, Elizabeth, and your company Theranos. And we congratulate you on this phenomenal rebooting of laboratory medicine. If there ever was a portion of medicine that probably needed creative destruction, this was it, and you figured out how to do it. Big-time kudos to you, and to all of your folks at Theranos. Thanks for being with us.

6 of 6
Latest in Internal Medicine


  1. Secretive Theranos emerging (partly) from shadows. San Francisco Business Journal. September 13, 2013. Accessed Novemeber 11, 2013.

  2. Theranos Raises $45M For Personalized Medicine. Xconomy. Accessed November 11, 2013.

  3. Theranos. Our Company. Accessed November 11, 2013.

  4. Theranos. Providers/Our Lab. Accessed November 11, 2013.

  5. Theranos. For Providers/Test Menu. Accessed November 11, 2013.

  6. The Father of Creative Destruction. Wired. March 2002. Accessed November 11, 2013.

  7. Rago J. Elizabeth Holmes: the breakthrough of instant diagnosis. Wall Street Journal. September 8, 2013. Accessed November 12, 2013.

Authors and Disclosures


Eric J. Topol, MD

Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California; Editor-in-Chief, Medscape

Disclosure: Eric J. Topol, MD, has disclosed the following relevant financial relationships:
Serve[d] as a director, officer, partner, employee, advisor, consultant, or trustee for: AltheaDX; Biological Dynamics; Cypher Genomics (Co-founder); Dexcom; Genapsys; Gilead Sciences, Inc.; Portola Pharmaceuticals; Quest Diagnostics; Sotera Wireless; Volcano
Received research grant from: National Institutes of Health; Qualcomm Foundation

Elizabeth Holmes

Founder, President, and CEO, Theranos, Inc., Palo Alto, California

Disclosure: Elizabeth Holmes has disclosed no relevant financial relationships.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:


All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.